Rlmd Stock Analysis Relmada Therapeutics Inc Slips 1.55 To 6.99 In Biotech Trading 20260403 MGRX Q3 2025 Earnings EPS Surprises with 069 Loss as Revenue Remains Undisclosed DCOMP Q1 2026 Earnings Preferred Dividend Coverage Slightly Below Expectations Nexalin Technology Q1 2026 Earnings EPS Misses Estimates Amidst Narrowing Losses Beyond Meat BYND Q1 2026 Earnings Narrower Loss Surprises Shares Edge Higher AIRO Q4 2025 Earnings Significant EPS Miss Beyond Expectations Stock Rises SUNC Q1 2026 Earnings Significant Earnings Miss Amid Challenging Quarter